Clinical Specialties Compounding Pharmacy recalls Avastin, (0.05 ml, 1.25 mg/0.05ml), single unit dose syringes, Clinical Specialties Compounding Pharmacy, Augusta, GA
Recalled September 4, 2013 · FDA recall D-918-2013 · Clinical Specialties Compounding Pharmacy
Hazard
Lack of Assurance of Sterility; product linked to adverse event reports of endophthalimitis eye infections and FDA inspection findings resulted in concerns regarding quality control processes · FDA Class II
Units
2190 syringes
Sold at
FL, GA, IN, LA and SC.
Description
Lack of Assurance of Sterility; product linked to adverse event reports of endophthalimitis eye infections and FDA inspection findings resulted in concerns regarding quality control processes
Product
Avastin, (0.05 ml, 1.25 mg/0.05ml), single unit dose syringes, Clinical Specialties Compounding Pharmacy, Augusta, GA
Manufacturer(s)
Clinical Specialties Compounding Pharmacy
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →